Showing results (481-490 of 513) with videos related to
Sort By:
Pageof 52
Biorxiv : the Preprint Server for Biology|June 25, 2024
Microbiota metabolized Bile Acids accelerate Gastroesophageal Adenocarcinoma via FXR inhibitionTheresa Baumeister, Andrea Proaño-Vasco, Amira Metwaly, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI RegistryUlrike Bauer, Maria R Troppmair, Najib Ben Khaled, et al.Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.Plos One|September 27, 2016
Open Surgical versus Minimal Invasive Necrosectomy of the Pancreas-A Retrospective Multicenter Analysis of the German Pancreatitis Study GroupSebastian Rasch, Veit Phillip, Stephanie Reichel, et al.The Lancet. Oncology|November 28, 2012
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Lorenza Rimassa, Ivan Borbath, et al.Circulation|January 22, 2018
Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult HeartMarkus Jabs, Adam J Rose, Lorenz H Lehmann, et al.Nature Communications|February 27, 2016
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in miceRoman Maresch, Sebastian Mueller, Christian Veltkamp, et al.Nature Communications|March 7, 2023
Non-canonical functions of SNAIL drive context-specific cancer progressionMariel C Paul, Christian Schneeweis, Chiara Falcomatà, et al.Biorxiv : the Preprint Server for Biology|March 30, 2023
Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancerH Carlo Maurer, Alvaro Garcia-Curiel, Sam R Holmstrom, et al.Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.Pageof 52